Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
15.27
-0.21 (-1.36%)
Oct 12, 2026, 12:41 PM EDT - Market open
Ultragenyx Pharmaceutical Market Cap
Ultragenyx Pharmaceutical has a market cap or net worth of $1.5 billion as of October 12, 2026. It is the 8,064th most valuable company in the world and the 1,973rd biggest in the United States. Its market cap has decreased by 50.48% in one year.
Market Cap
1.50B
Enterprise Value
2.27B
1-Year Change
-50.48%
Global Rank
Country Rank
#1,973 United States
Category
ChartMarket Cap Chart
Since January 31, 2014, Ultragenyx Pharmaceutical's market cap has increased from $1.19B to $1.50B, an increase of 26.24%. That is a compound annual growth rate of 1.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 1.50B | -32.36% |
| Dec 31, 2025 | 2.22B | -42.88% |
| Dec 31, 2024 | 3.88B | -1.06% |
| Dec 29, 2023 | 3.93B | 20.90% |
| Dec 30, 2022 | 3.25B | -43.33% |
| Dec 31, 2021 | 5.73B | -32.17% |
| Dec 31, 2020 | 8.45B | 242.48% |
| Dec 31, 2019 | 2.47B | 12.20% |
| Dec 31, 2018 | 2.20B | 11.33% |
| Dec 29, 2017 | 1.98B | -31.24% |
| Dec 30, 2016 | 2.87B | -34.05% |
| Dec 31, 2015 | 4.36B | 211.25% |
| Dec 31, 2014 | 1.40B | 17.73% |
| Jan 31, 2014 | 1.19B | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Stoke Therapeutics | 1.60B |
| uniQure | 1.57B |
| Korsana Biosciences | 1.54B |
| Innoviva | 1.53B |
| Syndax Pharmaceuticals | 1.52B |
| Immunocore Holdings | 1.51B |
| Maze Therapeutics | 1.51B |
| Kailera Therapeutics | 1.51B |